Risk of Obesity During a Gluten-free Diet in Pediatric and Adult Patients with Celiac Disease: a Systematic Review with Meta-analysis
Overview
Authors
Affiliations
Context: Obesity is a significant risk factor for many pathological conditions. Whether a gluten-free diet (GFD) is a risk factor for overweight or obesity remains controversial.
Objective: The primary aim of this study was to assess the prevalence of body mass index (BMI) categories at disease presentation and the variation in BMI category from underweight/normal to overweight/obese and vice versa during a GFD.
Data Sources: PubMed, Scopus, and Web of Science databases were searched through February 2021 for retrospective, cross-sectional, and prospective studies reporting BMI categories at disease diagnosis and during a GFD.
Data Extraction: Data were extracted by 2 reviewers independently. Disagreements were resolved by consensus; a third reviewer was consulted, if necessary. Risk of bias was assessed with the Cochrane ROBINS-I tool.
Data Analysis: Subgroup analysis based on age (pediatric/adult patients), study design (prospective, cross-sectional, retrospective), and duration of GFD was performed.. Forty-five studies were selected (7959 patients with celiac disease and 20 524 healthy controls). The mean BMI of celiac patients at presentation was significantly lower than that of controls (P < 0.001). During a GFD, the mean BMI increased significantly (mean difference = 1.14 kg/m2 [95%CI, 0.68-1.60 kg/m2]; I2 = 82.8%; P < 0.001), but only 9% of patients (95%CI, 7%-12%; I2 = 80.0%) changed from the underweight/normal BMI category to the overweight/obese category, while 20% (95%CI, 11%-29%; I2 = 85.8%) moved into a lower BMI category.
Conclusion: Most celiac patients had a normal BMI at presentation, although the mean BMI was significantly lower than that of controls. A GFD does not increase the risk of becoming overweight/obese, especially in children. The quality of several studies was suboptimal, with moderate or high overall risk of bias and heterogeneity.
Papoutsaki M, Katsagoni C, Papadopoulou A Nutrients. 2025; 17(3).
PMID: 39940345 PMC: 11820229. DOI: 10.3390/nu17030487.
Seidita A, Latteri F, Pistone M, Giuliano A, Bertoncello L, Cavallo G Nutrients. 2025; 17(1.
PMID: 39796519 PMC: 11722968. DOI: 10.3390/nu17010085.
Smeets S, Kiefte-de Jong J, van der Velde L BMJ Open. 2024; 14(10):e088069.
PMID: 39461855 PMC: 11529735. DOI: 10.1136/bmjopen-2024-088069.
Maleki F, Hosseinpour M, Delpisheh A, Bahardoust M, Hajizadeh-Sharafabad F, Pashaei M BMC Gastroenterol. 2024; 24(1):357.
PMID: 39385073 PMC: 11465624. DOI: 10.1186/s12876-024-03446-x.
Ahuja A, Pelton M, Raval S, Kesavarapu K Gastro Hep Adv. 2024; 2(6):860-872.
PMID: 39130122 PMC: 11307716. DOI: 10.1016/j.gastha.2023.06.010.